ABOUT USSOLUTIONESGINVESTORSMEDIA
CONTACTCAREERS
CONTACT
About Us
SOLUTION
ESG
INVESTORS
MEDIA
咨询事项CAREERS
한국어English汉语(简体)
漢語(繁體)

Governance

實踐“董事會中心經營模式”，提高企業價值與股東價值。
董事會
監事會
股東大會

董事會

HUGEL積極實踐“董事會中心經營模式”，以強化社會責任經營、提升企業價值和股東價值。
擁有獨立性、專業性以及多樣性的HUGEL董事會支持管理層的合理、透明的決策。

董事會的獨立性、專業性與多樣性

HUGEL董事會於2022年7月決定分離代表執行董事和董事長的職務，由其他非執行董事擔任董事長職務，以確保董事會運作的獨立性，進壹步提高監督工作的透明性。內部董事在各領域具備專業知識，並負責企業的整體運營。

董事會結構

截至2024年3月底，董事會共由7名董事組成（5名其他非常務董事、2名外部董事）。董事會就法律法規或章程規定的事項、股東大會的委任事項以及公司經營的基本方針和重要工作事項進行決議，並確保制度性機制，以保證合理決策和透明經營。

董事會

Title
Name
POSITION
Term
TITLE
NAME · POSITION · TERM
Non-executive Director
Suk-yong Cha
Chair of the Board of Directors,
Non-executive Director
Mar. 2023~Mar. 2026
Non-executive Director
Jon Huh
Non-executive Director
Mar. 2025~Mar. 2028
Non-executive Director
Michael Keyoung
Non-executive Director
Apr. 2025~Apr. 2028
Non-executive Director
Ki Chul Cho
Non-executive Director
Mar. 2024~Mar. 2027
Independent Director
Seungmin Chee
Chair of the Audit Committee, 
Non-executive Director
Apr. 2025~Apr. 2028
Non-executive Director
Taehyoung Lee
Member of the Audit Committee,
Non-executive Director
Apr. 2025~Apr. 2028
Independent Director
Patrick Holt
Member of the Audit Committee,
Independent Director
Apr. 2025~Apr. 2028

董事會活動

2024
2023
2022
2021
Date · Agenda
Date
Agenda
STATUS
ATTN
2024.12.05
Agenda 1: Trust Agreement for Treasury Stock Acquisition
Approved
7/7
2024.11.06
Report 1: Financial Statements for Q3 2024
Agenda 1: Decision on the Method of Exercising Stock Options
Agenda 2: Cancellation of stock option grants
Agenda 3: Approval of new facility installation
Agenda 4: Granting of Stock Options
Agenda 5: Payment of Performance Bonuses
Reported
Approved
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
7/7
2024.08.27
Agenda 1: Cancellation of Decision on the Stock Option Exercising Method
Agenda 2: Decision on the Method of Exercising Stock Options
Approved
Approved
7/7
7/7
2024.08.07
Report 1: Financial Statements for Q2 2024
Agenda 1: Relocation of the headquarters
Agenda 2: Appointment of Chief Compliance Officer
Agenda 3: Decision on the Method of Exercising Stock Options
Agenda 4: Cancellation of Stock Option Grants
Reported
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
2024.05.08
Report 1: Financial Statements for Q1 2024
Agenda 1: Decision on the Method of Exercising Stock Options
Reported
Approved
7/7
7/7
2024.03.27
Agenda 1: Trust Agreement for Treasury Stock Acquisition
Approved
7/7
2024.03.14
Report 1: Evaluation on the Audit Committee's Internal Accounting Control System Operation
Report 2: The Audit Committee’s 23rd term (for 2023) Report Submission
Agenda 1: Approval of the 2024 Business Plans
Agenda 2: Convening of the 23rd Annual General Shareholders' Meeting
Agenda 3: Decision on the Method of Exercising Stock Options
Reported
Reported
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
2024.02.13
Report 1: Financial Statements for Q4 2023
Report 2: Operation of the Internal Accounting Control System
Report 3: Operation of the Compliance Control System
Agenda 1: Approval of the 23rd Term (for 2023) Financial Statements
Agenda 2: Approval of the 23rd Term (for 2023) Sales Report
Agenda 3: Approval of the 2024 Occupational Safety and Health Business Plan
Agenda 4: Cancellation of Stock Option Grants
Agenda 5: Trust Agreement for Treasury Stock Acquisition
Reported
Reported
Reported
Approved
Approved
Approved
Approved
Approved
5/7
5/7
5/7
5/7
5/7
5/7
5/7
5/7
Date · Agenda
Date
Agenda
STATUS
ATTN
2023.12.22
Agenda 1 : Cancellation of Treasury Shares
Approved
4/7
2023.11.13
Report 1 : Report of the Year 2023 3Q Financial Statement
Agenda 1 : Treasury Stock Acquisition Trust Agreement
Reported
Approved
6/7
6/7
2023.09.08
Agenda 1 : Stock Acquisition Agreement for subsidiary Hugel America
Agenda 2 : Monetary Loan to subsidiary Hugel America
Approved
Approved
7/7
7/7
2023.08.09
Report 1 : Report of the Year 2023 2Q Financial Statement
Agenda 1 : Appointment of executive officers
Agenda 2 : Appointment of Representative Executive Officer
Reported
Approved
Approved
5/7
5/7
5/7
2023.07.14
Agenda 1 : Proposal to extend the maturity and conversion period of the 2nd unsecured private convertible bonds
Approved
4/7
2023.07.05
Agenda 1 : Proposal to convene a meeting of bondholders for the 2nd unsecured private convertible bonds
Approved
4/7
2023.05.09
Report 1 : Report of the Year 2023 1Q  Business Performance
Report 2 : Report of the Year 2023 1Q Financial Statement
Reported
Reported
7/7
7/7
2023.03.30
Agenda 1 : Appointment of  Chairman of the Board
Agenda 2 : Approval for granting stock purchase options
Agenda 3 : Approval of large-scale internal transactions
Agenda 4 : Proposal for cancellation of the grant of stock purchase options
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
2023.03.09
Report 1 : Report of internal accounting management system evaluation by the Audit Committee
Report 2 : Submission of the audit report for the 22nd term (2022.01.01~2022.12.31) by the Audit Committee
Agenda 1: Proposal to convene the 22nd regular shareholders' meeting
Agenda 2 : Appointment of Executive Officers
Agenda 3 : Proposal for investment in Hugel America
Agenda 4 : Proposal for the method of exercising stock purchase options
Reported
Reported
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
7/7
2023.02.14
Report 1 : Report of the evaluation of the internal accounting management system
Report 2 : Report of the evaluation of the compliance control system
Report 3 : Report of the subsidiary's delegated decision-making policy
Report 4 : Report of the 2022 KPI performance and 2023 goals
Agenda 1 : Approval of the 22nd (2022.01.01~2022.12.31) Financial Statement
Agenda 2 : Approval of the 22nd (2022.01.01~2022.12.31) Business Report
Agenda 3 : Approval of the 2023 business plan
Agenda 4 : Treasury Stock Acquisition Trust Agreement
Agenda 5 : Approval of the 2023 occupational safety and health business plan
Reported
Reported
Reported
Reported
Approved
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
7/7
7/7
7/7
7/7
Date · Agenda
Date
Agenda
STATUS
ATTN
2022.11.09
Report 1 : Progress schedule of investment in Hugel America
Agenda 1 : Proposal for the establishment and investment in overseas subsidiaries
Agenda 2 : Approval of concurrent directorship
Agenda 3 : Approval of the grant of stock purchase options
Agenda 4 : Approval of large-scale internal transactions
Agenda 5 : Cancellation of the grant of stock purchase options
Agenda 6 : Termination of the Meditech business
Reported
Approved
Approved
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
7/7
7/7
2022.09.20
Agenda 1 : Proposal to set the record date for the extraordinary shareholders' meeting
Agenda 2 : Proposal to convene the extraordinary shareholders' meeting
Agenda 3 : Treasury Stock Acquisition Trust Agreement extension
Approved
Approved
Approved
7/7
7/7
7/7
2022.08.10
Report 1 : Progress schedule for the approval of granting stock purchase options
Reported
7/7
2022.07.01
Agenda 1 : Appointment of  Chairman of the Board
Approved
7/7
2022.05.19
Agenda 1 : Proposal to convene the extraordinary shareholders' meeting
Agenda 2 : Proposal for setting the record date
Agenda 3 : Approval of adopting electronic voting
Approved
Approved
Approved
7/7
7/7
7/7
2022.04.14
Agenda 1 : Proposal to convene the extraordinary shareholders' meeting
Agenda 2 : Proposal for the division and purchase of convertible bonds
Approved
Approved
5/6
5/6
2022.04.07
Agenda 1 : Treasury Stock Acquisition Trust Agreement
Approved
5/6
2022.03.08
Report 1 : Report of internal accounting management system evaluation by the Audit Committee
Report 2 : Submission of the audit report for the 21st term (2021.01.01~2021.12.31) by the Audit Committee
Agenda 1 : Amendment of executive compensation regulations
Agenda 2 : Amendment of executive severance
Agenda 3 : Proposal to convene the 21st regular shareholders' meeting
Agenda 4 : Proposal to amend the record date for the extraordinary shareholders' meeting
Agenda 5 : Cancellation of granting stock purchase options
Reported
Reported
Approved
Approved
Approved
Approved
Approved
6/7
6/7
6/7
6/7
6/7
6/7
6/7
2022.02.10
Report 1 : Report of internal accounting management system evaluation
Agenda 1 : Approval of the 21st(2021.01.01~2021.12.31) Financial Statement
Agenda 2 : Approval of the 21st(2021.01.01~2021.12.31) Business Report
Agenda 3 : Liquidation of the Weihai Subsidiary
Agenda 4 : Liquidation of the Vietnam Subsidiary
Reported
Approved
Approved
Approved
Approved
6/7
6/7
6/7
6/7
6/7
2022.01.17
Agenda 1 : Proposal to set the record date for the extraordinary shareholders' meeting
Approved
7/7
Date · Agenda
DATE
AGENDA
STATUS
ATTN
2021.12.16
Agenda 1 : Proposal for setting the dividend record date
Approved
7/7
2021.12.13
Agenda 1 : Treasury Stock Acquisition Trust Agreement
Agenda 2 : Cancellation of Treasury Shares
Approved
Approved
6/7
6/7
2021.10.01
Agenda 1 : Proposal to set the record date for the extraordinary shareholders' meeting
Approved
6/7
2021.09.09
Agenda 1 : Treasury Stock Acquisition Trust Agreement extension
Approved
5/7
2021.04.08
Agenda 1 : Proposal for the method of exercising stock purchase options
Agenda 2 : Proposal for the transfer and cancellation/settlement of real estate contracts
Approved
Approved
7/7
7/7
2021.03.26
Agenda 1 : Reappointment of Co-Chairs of the Board
Agenda 2 : Appointment of Executive Directors
Approved
Approved
7/7
7/7
2021.03.10
Report 1 : Report of internal accounting management system evaluation by the Audit Committee
Report 2 : Submission of the audit report for the 20th term by the Audit Committee
Agenda 1 : Treasury Stock Acquisition Trust Agreement
Reported
Reported
Approved
7/7
7/7
7/7
2021.02.09
Report 1 : Report of internal accounting management system evaluation
Agenda 1 : Approval of the 20th (2020.01.01~2020.12.31) Financial Statement
Agenda 2 : Approval of the 20th (2020.01.01~2020.12.31) Business Report
Agenda 3 : Proposal to convene the 20th regular shareholders' meeting
Agenda 4 : Establishment of  the Compliance Control System
Agenda 5 : Appointment of Compliance Support Personnel
Reported
Approved
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
7/7

監事會

HUGEL基於公司章程第四十壹條第二款的條例成立並運營監事會。截至2024年12月底，監事會監事共有三人，由2名外部董事和1名其他非執行董事組成。監事會監事可以出席董事會會議，獨立監督董事的相關業務，並在與公司業務相關的事項上要求相關部門提交相關賬本和文件。此外，必要時也可以要求公司告知相關經營事項，並以適當的方式獲取經營信息。

監事會結構

Title · Name
Careers
Relationships with Shareholders
Term
TITLE · NAME · Careers · TERM
Audit Committee Chair
Seungmin Chee
• Ph.D. in Business Administration from the University of California at Berkeley
• Assistant Professor at the University of Oregon, Eugene
• Member of the Accounting System Deliberation Committee of the Securities and Futures Commission
• Non-executive Director at Korea Institute of Marine Science & Technology Promotion
• Associate Professor at  Korea University Business School
• Certified Public Accountant
- Certified Public Accountant, Deloitte Anjin Accounting Corporation (98.11~00.04, 03.02~03.09)
- Academic Director, Korean Accounting Association (2016~2017, 2018~2019)
- Editorial Board Member, Korean Accounting Association (2020-2021)
- Editorial Board Member, Korean Securities Association (2021-present)
None
Apr. 2025 ~ Apr. 2028
Audit Committee Member
Patrick Holt
• Bachelor's degree in Biochemistry from Monash University
• President Director, Merck & Co., Inc.
• Vice President, Allergan Inc.
• Non-Executive Director, Ascenda Loyalty
• President, Cordis(Cardinal Health Inc.)
None
Apr. 2025 ~ Apr. 2028
Audit Committee Member
Taehyoung Lee
• University of Washington MBA
• CEO, Incheon Total Energy Company
• Executive Vice President and Head of the Management Planning Division, GS Energy Co., Ltd.
• CFO, PM Team Leader, and Executive Vice President, GS Corporation
None
Apr. 2025 ~ Apr. 2028

監事會活動

2024

DATE · AGENDA
DATE
Agenda
STATUS
2024.11.05
Agenda 1: Approval of the Q3 2024 Financial Statement
Approved
2024.08.06
Agenda 1: Approval of the Q2 2024 Financial Statement
Approved
2024.05.07
Agenda 1: Approval of the Q1 2024 Financial Statement
Approved
2024.03.12
Agenda 1:  Confirmation of the Internal Accounting Management System Evaluation Report
Agenda 2: Submission of the Audit Committee's Opinion on Internal Monitoring Mechanisms
Agenda 3: Confirmation of the Audit Report for the 23rd Term (Fiscal Year of 2023) by the Audit Committee
Agenda 4: Review of the Legality of Agendas and Documents for the 23rd Annual Shareholders' Meeting
Approved
Approved
Approved
Approved
2024.02.13
Report 1: Report on Internal Accounting Management System Operations
Report 2: Approval of the 23rd (2023.01.01~2023.12.31) Financial Statement
Report 3: Approval of the 23rd (2023.01.01~2023.12.31) Sales Report
Report 4: Results of Periodic Designation of External Auditors
Reported
Reported
Reported
Reported

2023

DATE · AGENDA
DATE
Agenda
STATUS
2023.02.14
Report 1 : Report of internal accounting management system evaluation
Report 2 : Approval of the 22nd (2022.01.01~2022.12.31) Financial Statement
Report 3 : Approval of the 22nd (2022.01.01~2022.12.31) Business Report
Report 4 : Report of the periodic auditor designation results by external auditors
Reported
Reported
Reported
Reported
2023.03.08
Report 1 : Report of internal accounting management system plan for 2023
Agenda 1 : Approval of the internal accounting management system evaluation
Agenda 2 : Submission of the Audit Committee's opinion on internal monitoring mechanisms
Agenda 3 : Confirmation of the audit report for the 22nd term (2022 fiscal year) by the Audit Committee
Agenda 4 : Review of the legality of agendas and documents to be submitted to the 22nd regular shareholders' meeting
Reported
Approved
Approved
Approved
Approved
2023.05.09
Agenda 1 : Approval of the Year 2023 1Q Financial Statement
Approved
2023.08.08
Report 1 : Improvement measures of accounting system of the Financial Services Commission
Agenda 1 : Approval of the Year 2023 2Q Financial Statement
Reported
Approved
2023.11.07
Report 1 : Report of the management issues for the third quarter
Agenda 1 : Approval of the Year 2023 3Q Financial Statement
Reported
Approved

股東大會

2025

DATE · AGENDA
DATE
AGENDA
STATUS
The 24th Annual Meeting of Shareholders (2025.03.31)
1. Approval of the 24th Financial Statement
2. Appointment of Board Directors (Three Non-Executive Directors and One External Director)
3. Appointment of External Director Seungmin Chee as Audit Committee Member
4. Appointment of Two Members of Audit Committee
5. Approval of Compensation Limits for Directors
6. Approval of Granting of Stock Options
Approved
Approved
‍
Approved
‍
Approved
Approved
Approved

2024

DATE · AGENDA
DATE
AGENDA
STATUS
The 23rd Annual Meeting of Shareholders (2024.03.29)
1. Approval of the 23rd financial statements
2. Appointment of Directors (1 Non-Executive Director)
3. Approval of director remuneration limit
Approved
Approved
Approved

2023

DATE
AGENDA
STATUS
DATE · AGENDA
The 22nd Annual Meeting of Shareholders (2023.03.30)
1. Approval of the 22nd Financial Statement
2. Appointment of Directors (1 Non-Executive Director)
3. Approval of granting stock options
4. Approval of director remuneration limit
Approved
Approved
Approved
Approved

2022

DATE · AGENDA
DATE
AGENDA
STATUS
The 21st Annual Shareholders’ Meeting (2022.03.25)
1. Approval of the 21st Financial Statement
2. Approval of director remuneration limit
3. Amendment of executive severance
Approved
Approved
Approved
The 22nd Extraordinary Shareholders' Meeting (2022.04.29)
1. Appointment of Directors (4 Non-Executive Directors, 1 Independent Director)
2. Appointment of independent director, Seungmin Chee to a member of the Audit Committee
3. Appointment of the Audit Committee members
Approved
‍
Approved
‍
Approved
The 22nd Extraordinary Shareholders' Meeting (2022.06.29)
1. Appointment of Directors (1 Non-Executive Director)
‍
‍
Approved

‍
The 22nd Extraordinary Shareholders' Meeting (2022.10.28)
1. Amendment of Articles of Incorporation
2. Approval of granting stock purchase options
Approved
Approved
+

ESG

HUGEL秉持綠色經營，積極履行社會責任，基于透明公正的支配結構，引領實現可持續性美好生活。

+

ENVIRONMENTAL

HUGEL秉持綠色經營，積極履行社會責任，基于透明公正的經營結構，引領實現可持續性美好生活。

+

SOCIAL

HUGEL遵循注重人類尊嚴與價值的平等經營，積極履行社會責任，與所有員工、合作夥伴、地方社會等所有相關方共同追求可持續增長。

HUGEL
總部和巨頭工廠和研究所 | 江原特別自治道東內面巨頭園地1路23 | Tel. 033-815-5200
首爾地址 | 首爾特別市江南區三成路133路17 | Tel. 02-6966-1600
© 2024 HUGEL, Inc. All rights reserved.
使用條款
ㅣ
法律聲明
ㅣ
個人信息處理指南
FAMILY SITES